Dataset Information


MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.

ABSTRACT: LIN28B has been identified as an oncogene in various tumor entities, including neuroblastoma, a childhood cancer that originates from neural crest-derived cells, and is characterized by amplification of the MYCN oncogene. Recently, elevated LIN28B expression levels were shown to contribute to neuroblastoma tumorigenesis via let-7 dependent de-repression of MYCN. However, additional insight in the regulation of LIN28B in neuroblastoma is lacking. Therefore, we have performed a comprehensive analysis of the regulation of LIN28B in neuroblastoma, with a specific focus on the contribution of miRNAs. We show that MYCN regulates LIN28B expression in neuroblastoma tumors via two distinct parallel mechanisms. First, through an unbiased LIN28B-3'UTR reporter screen, we found that miR-26a-5p and miR-26b-5p regulate LIN28B expression. Next, we demonstrated that MYCN indirectly affects the expression of miR-26a-5p, and hence regulates LIN28B, therefore establishing an MYCN-miR-26a-5p-LIN28B regulatory axis. Second, we provide evidence that MYCN regulates LIN28B expression via interaction with the LIN28B promoter, establishing a direct MYCN-LIN28B regulatory axis. We believe that these findings mark LIN28B as an important effector of the MYCN oncogenic phenotype and underline the importance of MYCN-regulated miRNAs in establishing the MYCN-driven oncogenic process.


PROVIDER: S-EPMC4837470 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6049067 | BioStudies
1000-01-01 | S-EPMC5346721 | BioStudies
2020-01-01 | S-EPMC7036248 | BioStudies
2010-01-01 | S-EPMC3019350 | BioStudies
2020-01-01 | S-EPMC6944109 | BioStudies
2020-01-01 | S-EPMC7443143 | BioStudies
2016-01-01 | S-EPMC4947006 | BioStudies
2018-01-01 | S-EPMC5794903 | BioStudies
2017-01-01 | S-EPMC5556203 | BioStudies
2019-01-01 | S-EPMC6787501 | BioStudies